Biodesix
BDSX
#7218
Rank
$0.13 B
Marketcap
$1.44
Share price
-0.69%
Change (1 day)
-16.76%
Change (1 year)

P/E ratio for Biodesix (BDSX)

P/E ratio as of March 2024 (TTM): -1.31

According to Biodesix's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.30909. At the end of 2022 the company had a P/E ratio of -1.45.

P/E ratio history for Biodesix from 2020 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-1.45-57.07%
2021-3.37-83.66%
2020-20.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
28.8-2,299.94%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.0595-95.45%๐Ÿ‡บ๐Ÿ‡ธ USA
-16.5 1,162.08%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.